Harold Dauerman

BIO

Dr. Harold Dauerman received his Bachelor of Science from Yale University and his medical degree from Harvard Medical School. He subsequently trained in internal medicine, general and interventional cardiology at Massachusetts General Hospital and Beth Israel Hospital. Prior to joining the University of Vermont, Dr Dauerman served as Director, Interventional Cardiology at University of Massachusetts Medical Center. At UVM, he has served in multiple leadership roles including Director, Cardiovascular Catheterization Laboratories, Director of Cardiovascular Services and currently as Network Director, Interventional Cardiology. He is a tenured Professor in the Department of Medicine and currently serves as Vice Chair for Clinical Affairs overseeing the UVM Network Department of Medicine integrated clinical operations at 1 academic medical center and 5 community hospitals in Vermont and New York State. Dr. Dauerman has been involved in quality improvement initiatives, program development and care of high risk patients. This includes development of a region wide STEMI program, a comprehensive structural heart program and advising the national STEMI improvement initiative, Mission Lifeline. Dr. Dauerman planned the American Heart Association Scientific Sessions as prior Chair, Clinical Cardiology Council programming. Dr. Dauerman has served in multiple editor roles including Editor in Chief (Coronary Artery Disease), Senior Guest Editor (Circulation: Cardiovascular Interventions) and Executive Editor (Journal of the American College of Cardiology). Dr. Dauerman has served as a clinical and research mentor for many UVM Cardiology graduates and has held national leadership roles in multicenter registries and clinical trials across a broad spectrum of interventional cardiology research areas.

Dr. Dauerman's postdoctoral training

Fellowship, Cardiology and Interventional Cardiology, Beth Israel Hospital

Internship and Residency, Massachusetts General Hospital

Dr. Dauerman's professional associations

Member, American College of Cardiology

Member, Society of Cardiac Angiography and Interventions

Dr. Dauerman's publications

Gupta T, Zimmer J, Lahoud RN, Murphy HR, Harris AH, Kolte D, Hirashima F, Dauerman HL. National trends and outcomes of acute myocardial infarction after transcatheter aortic valve replacement. JACC Cardiovascular Interventions 2024; 17: 1267-1276.

Dauerman HL. Optical Coherence Tomography—Light and Truth. New England Journal of Medicine, 2023; 389: 1523-1525.

Dauerman HL, Turco J, Fuster VF. Artificial Intelligence, Bob Dylan and Cardiovascular Scholarship. J Am Coll Cardiol 2023; 82: 961-963.. Dauerman HL. Medicine, Writing, and the Limits of Language. .JAMA Cardiol. 2022; 7:783-784

Sharma T, Krishan AM, Lahoud RL, Polomsky M, Dauerman HL. National Trends in SAVR and TAVR for Patients with Severe Isolated Aortic Stenosis. J Am Coll Cardiol 2022; 80: 2054-2056.

Araki M, Park SJ, Dauerman HL et al. Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nature Reviews Cardiology 2022; 19: 684-703.

Ehtisham Mahmud, Harold L. Dauerman, Frederick GP Welt et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic. J Am Coll Cardiol 2020; 76: 1375-1384.

Nambiar L, Lewinter MM, VanBuren PC, Dauerman HL.Recent Trends in Hypertension Related Cardiovascular Deaths in the United States. Journal of the American College of Cardiology, 2020; 75: 2644-2646.

Awards and Achievements

Distinguished Investigator, Cardiovascular Research Institute of Vermont (2023)

Castle Connolly Top Doctor (2022-2025)

Dean’s Excellence in Research Award (Clinical Trials), University of Vermont, Larner College of Medicine (2020)

Simon Dack Award for Outstanding Scholarship, American College of Cardiology (2016)

Induction to Association of University Cardiologists (2016)